Healthcare & Life Sciences
Renibus Therapeutics
United Statesrenibus.com
Renibus Therapeutics is a startup based in the United States.
About Renibus Therapeutics
Renibus Therapeutics is a company headquartered in the United States.
Renibus Therapeutics is a clinical-stage biopharmaceutical company developing therapies to prevent disease progression, improve outcomes, and protect against organ damage in cardio, renal, and metabolic diseases, with multiple assets in clinical trials including the Phase 3 candidate Veverimer.
Explore Renibus Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.